Acting Attorney General Todd Blanche said he is immediately moving medical marijuana from Schedule I to Schedule III, which ...

The PIONEER TEENS trial compared oral semaglutide at maximum tolerated doses with placebo in adolescents aged 10 to 17 years with T2D.

The order places FDA-approved products containing marijuana and state-regulated medical marijuana products at a lower drug ...

A cannabis industry group calls President Donald Trump’s reclassification of state-licensed medical marijuana as a ...

Novo Nordisk A/S NVO reported positive topline results from its late-stage PIONEER TEENS trial, showing that oral semaglutide ...

Acting Attorney General Todd Blanche signed an order under President Trump’s direction on Thursday to reclassify ...

President Trump's move reclassifies medical marijuana as a Schedule III drug. Discover what types of drugs marijuana is now classified with. (AP Photo) ...

Novo Nordisk (NVO) stock gains after oral semaglutide pill succeeds in pediatric type 2 diabetes trial. Company targets H2 ...

Novo Nordisk’s oral GLP-1 therapy significantly lowered blood sugar in children and adolescents with type 2 diabetes in a late-stage trial, marking the first study of this drug class in the age group.

Novo Nordisk's oral GLP-1 pill achieved its main target in a late-stage diabetes study involving children and adolescents ...

Novo Nordisk's oral GLP-1 drug significantly lowered blood sugar levels in children and adolescents with ​type 2 diabetes, ...

Twelve million people lost coverage for Zepbound over the last year. The same number of people lost coverage for Wegovy, ...